Gujarat Themis Biosyn Share Price
411.35-13.75 (-3.23%)
+4.56% past 1 Year
Incorporated in 1981 as a joint sector company with GIIC Ltd. and Chemosyn (P) Ltd. Commenced production in August, 1985 by producing Erythromycin and Erythromycin salts and formulations. The Company
Corporate filings & documents
Announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pharmaceutical Business Group India Ltd & Others
2 days agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Pharmaceutical Business Group India Ltd & Others
2 days agoKindly refer to the outcome of the Board Meeting held on 01-09-2026
2 days agoKindly refer to the outcome of the Board Meeting held on 01-09-2026
2 days agoOutcome of the Fund Raising Committee held on 28.08.2026 for allotment of equity shares through QIP
6 days agoOutcome of Fund Raising Committee for QIP Issue Close
6 days agoOutcome of Fund Raising Committee for QIP Issue Close
6 days agoGujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 inter alia to consider and approve Please refer to the intimation of the Board Meeting to be held on 01-09-2026
1 week agoGujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 inter alia to consider and approve Please refer to the intimation of the Board Meeting to be held on 01-09-2026
1 week agoPlease refer to the attachment
1 week agoPlease refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)
1 week agoPlease refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment.
1 week agoPlease refer to the attachment
1 week agoPlease refer to the attachment
1 week agoPlease refer to the outcome / proceedings of EGM held on 22.08.2026
1 week agoPlease refer to the outcome / proceedings of EGM held on 22.08.2026
1 week agoEarnings Call Transcript
2 weeks agoPlease refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday August 10 2026 (IST).
3 weeks agoPlease refer to our submission of Call Recordings of the investor/analyst Conference Call held on Monday August 10 2026 (IST).
3 weeks agoPlease refer to the copies of newspaper articles published for the un-audited financial results for the quarter ended 30.06.2026
3 weeks agoPlease refer to the copies of newspaper articles published for the un-audited financial results for the quarter ended 30.06.2026
3 weeks agoPlease refer to our investors presentation for the quarter ended 30.06.2026
3 weeks agoPlease refer to our investors presentation for the quarter ended 30.06.2026
3 weeks agoPlease refer to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026
4 weeks agoPlease refer to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026
4 weeks agoPlease refer to the outcome of the Board meeting held on 07.08.2026
4 weeks agoPlease refer to the outcome of the Board meeting held on 07.08.2026
4 weeks agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sachin D Patel
1 month agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sachin D Patel
1 month agoPlease refer to the concall invite to discuss the 1QFY27 Financial performance.
1 month agoPlease refer to the concall invite to discuss the 1QFY27 Financial performance.
1 month agoPlease refer to the copies of Newspaper Publication of EGM Notice.
1 month agoPlease refer to the copies of Newspaper Publication of EGM Notice.
1 month agoPlease refer to the attachment.
1 month agoPlease refer to the attachment.
1 month agoGujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve the Un-Audited Financial Results for the quarter ended on 30th June 2026 and Limited Review Reports of the Auditor thereon;
1 month agoGujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve the Un-Audited Financial Results for the quarter ended on 30th June 2026 and Limited Review Reports of the Auditor thereon;
1 month agoPlease refer to our copies of Newspaper Publication dated 24.07.2026 for Postal Ballot.
1 month agoPlease refer to our copies of Newspaper Publication dated 24.07.2026 for Postal Ballot.
1 month agoPlease refer to the Notice of Postal Ballot 22.07.2026
1 month agoThe Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 21 2026 for Pharmaceutical Business Group (India) Ltd
1 month agoThe Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 21 2026 for Pharmaceutical Business Group (India) Ltd
1 month agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2025-09-04
Dividend
0.67
2024-08-09
Bonus
1:2
2024-07-15
Dividend
0.25
2024-02-22
Dividend
0.75
2023-10-10
Split
5:1
2023-09-01
Dividend
1.0
2022-12-02
Dividend
4.4
Company details
Registered office
69 / C G I D C Industrial Estate Vapi Valsad Dist Gujarat PIN: 396195 Tel No: 0260-2430027 / 2400639 Fax No: 0260-2400638 Email: [email protected] Internet: www.gtbl.in
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Vineet G Gawankar, Company Secretary & Compliance Officer
Dinesh S Patel, Chairman
Sachin D Patel, Managing Director
Kirandeep Kaur Madan, Non Executive Independent Director
Hitesh Gajaria, Non Executive Independent Director
KG Ananthakrishnan, Non Executive Independent Director
Nihar Parikh, Non Executive Independent Director
Rajneesh Anand, Non Independent & Non Executive Director
Details
BSE 506879
NSE GUJTHEM
ISIN INE942C01045